Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Molecular Characterization for Understanding Biliary Atresia — Stella

Home/Biliary Atresia/Molecular Characterization for Understanding Biliary Atresia

View on ClinicalTrials.gov

Recruiting

Back to Biliary Atresia trials

Molecular Characterization for Understanding Biliary Atresia

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

France

Hopital Necker enfants malades, Paris, De

PRC Inserm, Paris

Key details

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Enrollment target

~100 participants

Started

February 2021

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Last updated June 2021

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.